Nuclear Medicine: Page 31

BWXT and Bayer to focus on therapeutic radionuclides

By AuntMinnie.com staff writers

BWXT Medical and Bayer have entered an agreement to ramp up their supply of actinium-225 as both companies seek to broaden commercialization strategies for targeted radionuclide therapies.

September 15, 2021

Cardiac PET predicts outcomes in aortic stenosis

By Will Morton

PET imaging has shown how impaired blood flow in small vessels of the heart may lead to myocardial stress and injury in patients with aortic stenosis, according to a study published online September 15 in JAMA Cardiology.

September 15, 2021

IBA, SCK CEN sign actinium-225 deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

AI can detect metastatic bone lesions on scintigraphy

By Erik L. Ridley

An artificial intelligence (AI) algorithm can identify and characterize suspicious bone lesions on whole-body bone scintigraphy exams in cancer patients, according to research published online September 4 in BMC Medical Imaging.

September 12, 2021

PET identifies early responders to liver cancer treatment

By Will Morton

PET imaging can predict how liver cancer patients are going to respond early after transarterial radioembolization, according to a study published online September 8 in the American Journal of Roentgenology.

September 9, 2021

NorthStar, Point Biopharma ink Ac-225 supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and Point Biopharma Global have signed a supply agreement covering the development and commercialization of the medical radioisotope actinium-225 (Ac-225).

September 7, 2021

Telix, Kettering to research PSMA radiotracer

By AuntMinnie.com staff writers

Kettering Health and Telix Pharmaceuticals have signed a deal to study Telix's investigational prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical, illuccix.

September 7, 2021

Hermes, Isotopia sign deal on dosimetry

By AuntMinnie.com staff writers

Nuclear medicine software developer Hermes Medical Solutions has signed a collaboration with Isotopia Molecular Imaging to support clinical studies to demonstrate the positive effects of personalized dosimetry and modulated radiopharmaceutical therapy on patient outcomes.

September 6, 2021

PET reveals triple threat behind Alzheimer's dementia

By Will Morton

PET imaging has shown for the first time how a triple threat of brain activity drives dementia in Alzheimer's disease patients -- and researchers created a visual map that lights up the culprit in action. Study details were published August 26 in Nature Medicine.

August 30, 2021

NorthStar wins $37M DOE award for Mo-99 production

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) Nuclear Security Administration has bestowed a $37 million award to NorthStar Medical Radioisotopes for the production of molybdenum-99 (Mo-99).

August 29, 2021

Iotron, CIIC to produce radioisotope Cu-67

By AuntMinnie.com staff writers

Iotron Medical and Canadian Isotope Innovations (CIIC) will produce the radioisotope copper-67 (Cu-67) for new cancer therapies.

August 24, 2021

Telix works with Merck on cancer therapies

By AuntMinnie.com staff writers

Telix Pharmaceuticals is entering into a collaboration with Merck for research studies on the combination of Merck's DNA damage response inhibitor molecules with Telix's therapeutic radiotracers.

August 19, 2021

Previous Page

Page 31 of 439

Next Page